Chronic leukaemias in the community

Area of Science:

• Hematology
• Oncology
• Pharmacology

Background:

• Chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL) patients are increasingly managed outpatient.
• Novel oral targeted therapies have significantly improved survival, approaching general population life expectancy.
• Suboptimal drug adherence is a major cause of treatment failure and adverse outcomes.

Purpose of the Study:

• To highlight the challenges associated with long-term oral targeted therapy in CML and CLL.
• To emphasize the impact of drug adherence, drug-drug interactions, and gastric pH on treatment efficacy.
• To raise awareness of potential fatal complications from long-term use of these novel agents.

Main Methods:

• This is a review of current management strategies and challenges for CML and CLL patients on oral targeted therapies.
• Analysis of factors affecting pharmacokinetics, including drug-drug interactions and gastric pH.
• Review of documented long-term complications associated with these treatments.

Main Results:

• Improved survival outcomes due to targeted oral treatments.
• Significant impact of drug adherence and pharmacokinetic alterations on treatment effectiveness.
• Potential for serious, even fatal, complications such as cardiovascular events and infections.

Conclusions:

• Long-term management of CML and CLL requires careful monitoring of oral targeted therapy adherence.
• Understanding drug-drug interactions and gastric pH is crucial for optimizing treatment outcomes.
• Vigilance for and prompt recognition of potential complications are essential for patient safety.